Company: DVAX
Filing Date: 2025-04-15
Form Type: PRER14A
Source: 0000930413-25-001254
Chunk: 80

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-15
Form: PRER14A
Chunk 80
---
 U.S. and Europe, our peer group targeted the following profiles,
where possible:

| • | Commercial-stage companies;                  |
| • | Pure-play or related vaccine developers; and |
| • | Integrated manufacturing operations          |

| 64 |

The change in our peer group from 2023 to 2024 included
removing 3 companies for various reasons including acquisitions, or market caps or revenue that were out of range. The companies that
were removed were Radius Health, Inc., Sarepta Therapeutics, Inc. and Zogenix, Inc. The following eight companies were added to the peer
group: Collegium Pharmaceuticals, Inc., Exelixis, Inc., Harmony Biosciences Holdings, Inc., Ionis Pharmaceuticals, Inc., Novavax, Inc.,
PTC Therapeutics, Inc., Vir Biotechnology, Inc. and Vaxcyte, Inc. As of August 2023, the point at which the Compensation Committee approved
the 2023-2024 peer group, the companies in the 2023-2024 peer group had market capitalizations ranging between approximately $380.5 million
to $6.4 billion, and the median market capitalization of our peer group was $1.7 billion. At the same point in time, our market capitalization
was $1.825 billion. The following table lists our 2023-2024 peer group which was applicable to performance year 2024 compensation:

| • | Acadia Pharmaceuticals, Inc.    |     | • | Exelixis, Inc.                 |     | • | Novavax, Inc.                  |
| • | Agenus, Inc.                    |     | • | Fibrogen, Inc.                 |     | • | Pacira BioSciences, Inc.       |
| • | Alector, Inc.                   |     | • | Harmony Biosciences, Inc.      |     | • | PTC Therapeutics, Inc.         |
| • | Amicus Therapeutics, Inc.       |     | • | Immunogen, Inc.                |     | • | Supernus Pharmaceuticals, Inc. |
| • | Collegium Pharmaceuticals, Inc. |     | • | Ionis Pharmaceuticals, Inc.    |     | • | Travere Therapeutics, Inc.     |
| • | Corcept Therapeutics, Inc.      |     | • | Ironwood Pharmaceuticals, Inc. |     | • | Vaxcyte, Inc.                  |
| • | Eagle